Insider Transactions in Q2 2023 at Corcept Therapeutics Inc (CORT)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2023
|
Gary Charles Robb Chief Business Officer |
SELL
Bona fide gift
|
Direct |
600
-2.91%
|
-
|
|
Jun 08
2023
|
Gary Charles Robb Chief Business Officer |
BUY
Bona fide gift
|
Indirect |
2,175
+8.25%
|
-
|
|
Jun 08
2023
|
Gary Charles Robb Chief Business Officer |
SELL
Bona fide gift
|
Direct |
3,550
-3.13%
|
-
|
|
Jun 06
2023
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
10,000
-66.09%
|
$230,000
$23.6 P/Share
|
|
Jun 06
2023
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+39.79%
|
$110,000
$11.35 P/Share
|
|
Jun 01
2023
|
Sean Maduck |
BUY
Grant, award, or other acquisition
|
Direct |
3,316
+2.61%
|
$36,476
$11.49 P/Share
|
|
Jun 01
2023
|
Atabak Mokari Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,302
+20.26%
|
$36,322
$11.49 P/Share
|
|
Jun 01
2023
|
Joseph Douglas Lyon |
BUY
Grant, award, or other acquisition
|
Direct |
2,822
+24.53%
|
$31,042
$11.49 P/Share
|
|
Jun 01
2023
|
Gary Charles Robb Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,182
+8.3%
|
$46,002
$11.49 P/Share
|
|
May 10
2023
|
Gary Charles Robb Chief Business Officer |
SELL
Open market or private sale
|
Direct |
14,000
-41.18%
|
$336,000
$24.07 P/Share
|
|
May 09
2023
|
Gary Charles Robb Chief Business Officer |
SELL
Open market or private sale
|
Direct |
30,000
-46.88%
|
$690,000
$23.87 P/Share
|
|
May 08
2023
|
David L Mahoney |
SELL
Payment of exercise price or tax liability
|
Indirect |
2,197
-0.18%
|
$50,531
$23.76 P/Share
|
|
May 08
2023
|
David L Mahoney |
BUY
Exercise of conversion of derivative security
|
Indirect |
30,000
+2.36%
|
$30,000
$1.74 P/Share
|
|
May 05
2023
|
Gary Charles Robb Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
60,586
-48.63%
|
$1,454,064
$24.07 P/Share
|
|
May 05
2023
|
Gary Charles Robb Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
105,000
+36.79%
|
$210,000
$2.61 P/Share
|